Hiramatsu M

References (4)

Title : Effects of galantamine on social interaction impairments in cholecystokinin receptor-2 overexpression mice - Tanase_2022_J.Pharmacol.Sci_148_364
Author(s) : Tanase S , Mamiya T , Nagata S , Ikawa Y , Tang YP , Hiramatsu M , Nabeshima T
Ref : J Pharmacol Sci , 148 :364 , 2022
Abstract :
PubMedSearch : Tanase_2022_J.Pharmacol.Sci_148_364
PubMedID: 35300811

Title : Galantamine improves enhanced impulsivity, impairments of attention and long-term potentiation induced by prenatal nicotine exposure to mice - Mamiya_2020_Biochem.Pharmacol__114139
Author(s) : Mamiya T , Tanase S , Takeuchi S , Kato S , Ito A , Hiramatsu M , Nabeshima T
Ref : Biochemical Pharmacology , :114139 , 2020
Abstract :
PubMedSearch : Mamiya_2020_Biochem.Pharmacol__114139
PubMedID: 32652142

Title : Serum cytokeratin 18 M30 antigen level and its correlation with nutritional parameters in middle-aged Japanese males with nonalcoholic fatty liver disease (NAFLD) - Tabuchi_2010_J.Nutr.Sci.Vitaminol.(Tokyo)_56_271
Author(s) : Tabuchi M , Tomioka K , Kawakami T , Murakami Y , Hiramatsu M , Itoshima T , Sugawara S , Kawashima A , Okita M , Tsukamoto I
Ref : J Nutr Sci Vitaminol (Tokyo) , 56 :271 , 2010
Abstract :
PubMedSearch : Tabuchi_2010_J.Nutr.Sci.Vitaminol.(Tokyo)_56_271
PubMedID: 21228496

Title : Properties of Suc-GPLGP-MCAase and dipeptidyl-aminopeptidase in mouse calvaria-derived osteoblastic cells (MC3T3-E1) - Chikuma_1985_Calcif.Tissue.Int_37_183
Author(s) : Chikuma T , Ishii Y , Kato T , Hiramatsu M , Kumegawa M
Ref : Calcif Tissue Int , 37 :183 , 1985
Abstract :
PubMedSearch : Chikuma_1985_Calcif.Tissue.Int_37_183
PubMedID: 2988719